ALK and familial pancreatic carcinoma: Additionally, it has been shown that blocking ALK signaling by TAE684 exerts anti-tumor effects in pancreatic cancer [22], while ALK inhibition by crizotinib suppresses pancreatic tumor growth, cell proliferation, and angiogenesis and induces apoptosis [23].